These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8764693)

  • 21. Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research.
    McConnell JD; Barry MJ; Bruskewitz RC
    Clin Pract Guidel Quick Ref Guide Clin; 1994 Feb; (8):1-17. PubMed ID: 7507389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of benign prostatic hypertrophy: present situation and future prospects].
    Vicente Rodríguez J
    Actas Urol Esp; 2002; 26(7):481-90. PubMed ID: 12224431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of benign prostatic hyperplasia: surgery, medical therapy, or watchful waiting.
    Sall M; Bruskewitz RC
    Compr Ther; 1996 Sep; 22(9):554-8. PubMed ID: 8902346
    [No Abstract]   [Full Text] [Related]  

  • 24. Benign prostatic hyperplasia.
    Chisholm GD; Khan MS
    Practitioner; 1992 Mar; 236(1512):325-7. PubMed ID: 1378611
    [No Abstract]   [Full Text] [Related]  

  • 25. [Urogenital disorders in elderly patients].
    Nakayama H; Ogura H
    Nihon Naika Gakkai Zasshi; 2004 Dec; 93(12):2566-71. PubMed ID: 15658486
    [No Abstract]   [Full Text] [Related]  

  • 26. Review of current and future approaches to the management of benign prostatic hyperplasia.
    Gingell JC
    Postgrad Med J; 1992 Sep; 68(803):702-6. PubMed ID: 1282714
    [No Abstract]   [Full Text] [Related]  

  • 27. Managing benign prostatic hyperplasia.
    Garnett S; Abrams P
    Practitioner; 2001 Oct; 245(1627):830-2, 834, 836 passim. PubMed ID: 11677898
    [No Abstract]   [Full Text] [Related]  

  • 28. Endocrine and adrenergic pharmacological intervention in diseases of the prostate.
    Rane A
    Br J Clin Pharmacol; 1998 Apr; 45(4):329-37. PubMed ID: 9578179
    [No Abstract]   [Full Text] [Related]  

  • 29. [Non surgical treatment of benign prostatic hypertrophy. Past, present and future].
    Rossetti R
    J Urol (Paris); 1993; 99(6):367-8. PubMed ID: 7516394
    [No Abstract]   [Full Text] [Related]  

  • 30. What will replace TURP?
    Brawer MK; McConnell JD; Oesterling JE
    Contemp Urol; 1992 Feb; 4(2):30-40. PubMed ID: 10151029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapy for benign prostatic hyperplasia.
    Narayan P; Indudhara R
    West J Med; 1994 Nov; 161(5):495-506. PubMed ID: 7528957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benign Prostatic Obstruction Relief in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Enlargement Undergoing Endoscopic Surgical Procedures or Therapy with Alpha-Blockers: A Review of Urodynamic Studies.
    Fusco F; Creta M; Imperatore V; Longo N; Imbimbo C; Lepor H; Mirone V
    Adv Ther; 2017 Apr; 34(4):773-783. PubMed ID: 28255867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Non surgical treatment of benign prostatic hypertrophy].
    Martini E; Vaggi L; Rucci A; Di Clemente L
    J Urol (Paris); 1993; 99(6):278-82. PubMed ID: 7516366
    [No Abstract]   [Full Text] [Related]  

  • 34. Benign prostatic hyperplasia (BPH) therapy: when? how? why? the take-home message.
    Marberger M
    J Urol (Paris); 1995; 101(1):56-7. PubMed ID: 7545734
    [No Abstract]   [Full Text] [Related]  

  • 35. Benign Prostatic Hyperplasia.
    Langan RC
    Prim Care; 2019 Jun; 46(2):223-232. PubMed ID: 31030823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A randomized long-term comparative study of clinical efficacy of alpha 1-blocker with or without antiandrogen therapy for benign prostatic hyperplasia: focusing on improvement of I-PSS].
    Ohtani M; Kikuchi K; Tsuchiya A; Noguchi R; Akaza H; Kondo F; Koiso K
    Hinyokika Kiyo; 2000 Nov; 46(11):791-7. PubMed ID: 11193299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Approach to benign hypertrophy of the prostate in primary health care].
    Bentué Ferrer C; Córdoba García R
    Aten Primaria; 1995 Apr; 15(7):461-4. PubMed ID: 7539299
    [No Abstract]   [Full Text] [Related]  

  • 38. Benign prostatic hyperplasia: drug and nondrug therapies.
    Bruskewitz RC
    Geriatrics; 1992 Dec; 47(12):39-42, 45. PubMed ID: 1280242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride.
    Zlotta AR; Teillac P; Raynaud JP; Schulman CC
    Eur Urol; 2005 Aug; 48(2):269-76. PubMed ID: 15939527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benign prostatic hyperplasia. The Saudi perspective in the year 2000.
    Mosli HA; Atwa MA; Mahassini SH
    Saudi Med J; 2000 Oct; 21(10):915-20. PubMed ID: 11369951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.